Clinical presentations of chlamydial and non-chlamydial reactive arthritis

Rheumatol Int. 2006 Aug;26(10):879-85. doi: 10.1007/s00296-005-0094-z. Epub 2006 Jan 24.

Abstract

The aim of this study was to investigate the triggering micro-organisms and the clinical as well as laboratory differences between Chlamydial and non-chlamydial reactive arthritis (ReA) in a prospective study on 98 patients with acute/subacute arthritis. An inciting organism was found in 42 patients. Eighteen of these were chlamydial. Fifty-seven percent of all ReA patients were carriers for HLA-B27, which increased to 67% in the chlamydial group. Chlamydial ReA patients had more urethritis (P<0.05) with a longer period between arthritis and inciting infection, significantly lower CRP levels, and involved joint counts (P<0.05). Additionally, sacroiliitis was more frequent besides extra-articular manifestations in chlamydial ReA group. This study shows that chlamydial ReA differs in some points from non-chlamydial ReA, which in turn may affect the evaluation of an arthritic patient. ReA due to chlamydia more frequently encompasses a monoarticular or oligoarticular clinical picture with predominant distal extremity involvement. Non-chlamydial ReA presents higher joint counts and may involve upper extremity joints.

Publication types

  • Comparative Study

MeSH terms

  • Adolescent
  • Adult
  • Arthritis, Reactive / diagnosis
  • Arthritis, Reactive / immunology
  • Arthritis, Reactive / microbiology*
  • Arthritis, Reactive / pathology
  • Arthritis, Reactive / physiopathology
  • C-Reactive Protein / analysis
  • Chlamydia Infections / complications*
  • Chlamydia Infections / diagnosis
  • Chlamydia Infections / microbiology
  • Chlamydia trachomatis / isolation & purification
  • Echocardiography
  • Electrocardiography
  • Female
  • HLA-B27 Antigen / analysis
  • HLA-B27 Antigen / immunology
  • Humans
  • Joints / pathology
  • Joints / physiopathology
  • Male
  • Prohibitins
  • Prospective Studies

Substances

  • HLA-B27 Antigen
  • PHB2 protein, human
  • Prohibitins
  • C-Reactive Protein